New injection aims to tame dangerous pregnancy condition

NCT ID NCT07282171

Recruiting now Disease control Sponsor: Comanche Biopharma Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a single injection of CBP-4888 in 60 pregnant women hospitalized with preterm preeclampsia, a serious condition involving high blood pressure and organ stress. The goal is to find a safe dose and see if the drug can lower a harmful protein called sFlt1. Participants receive standard care plus the study drug, and both mothers and babies are followed for months after delivery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CBP-4888 (a drug given as a single injection under the skin)
What this could lead to: If it works, this could lead to a new treatment that helps manage preterm preeclampsia by lowering a harmful protein in the blood, potentially allowing safer continuation of pregnancy.
What could go wrong: This is an early Phase 1 trial with only 60 participants, so safety and effectiveness are not yet proven. The drug may not lower the protein enough or could cause unexpected side effects in mothers or babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia Toxemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA PRETERM PREECLAMPSIA SFLT1 MEDIATED PRETERM PREECLAMPSIA

Contacts and locations

Locations

Monash University
RECRUITING

Melbourne, Australia
Royal Melbourne
RECRUITING

Melbourne, Australia
The Royal Women's Hospital
RECRUITING

Parkville, Victoria, 3052, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.